Birmingham research tackles liver transplant failure HealthCanal.com The trial involved 23 patients undergoing liver transplantation. Thirteen control patients did not receive the drug, and the remaining 10 patients were given ITX5061 on the day of their transplant and for a week afterwards. The levels of HCV in all ... |
